CAS 51876-97-2

Alrestatin sodium

CAS: 51876-97-2

Alrestatin sodium is a diagnostic agent that can be used to diagnose pancreatic disease. It has been shown to decrease plasma glucose and enhance the uptake of glucose into tissues. Alrestatin sodium is also used in pharmaceutical preparations, including those for the treatment of fatty acid esters, fatty alcohols, and irritants. This drug is available as an injection or intravenous drip.

Formel: C₁₄H₈NNaO₄

Reinheit: Min. 95%

Molekulargewicht: 277.21 g/mol

Ref: 3D-BCA87697

Alrestatin Sodium

CAS: 51876-97-2

Alrestatin is a specific inhibitor of the aldose reductase enzyme.

Formel: C₁₄H₉NNaO₄

Reinheit: 98%

Farbe und Form: Solid

Molekulargewicht: 278.219

Ref: TM-T5195L